Skip to main content
Equibles

UBS Group AG

Position in BDRX — Biodexa Pharmaceuticals Plc

CIK 1610520 ZURICH, V8
Back to BDRX Full portfolio

Position in BDRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$72
-$6 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 8 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BDRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. BDRX ranks #536 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in BDRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $72 25
2026-03-31 $78 127
2025-12-31 $4,766 2,100
2025-09-30 $46,051 6,925
2025-06-30 $1,720 1,989
2025-03-31 $24,858 18,832
2024-12-31 $28,540 7,047
2024-09-30 $72,035 255,446
2024-06-30 $8,957 9,997
2024-03-31 $3,949 2,438
2023-12-31 $1,608 600
2023-09-30 $354 71
2023-06-30 $9,812 142,208